Liquidia (NASDAQ:LQDA) Stock: Insider Dana Boyle Sells 1,581 Shares

Liquidia Corporation (NASDAQ:LQDA) CAO Dana Boyle sold 1,581 shares of the firm’s stock in a transaction on Monday, October 26th. The stock was sold at an average price of $43.19, for a total value of $68,283.39. Following the sale, the chief accounting officer owned 164,028 shares in the company, valued at $7,084,369.32. This trade represents a 0.95% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Dana Boyle also recently made the following trade(s):

• On Monday, October 12th, Dana Boyle sold 5,892 shares of Liquidia stock. The shares were sold at an average price of $28.48, for a total value of $167,804.16.

Liquidia Stock Performance

NASDAQ LQDA opened at $44.99 on Friday. The business’s 50-day moving average price is $53.51 and its 200 day moving average price is $54.26. Liquidia Corporation has a twelve month low of $22.21 and a twelve month high of $93.61. The company has a market capitalization of $4.03 billion, a PE ratio of 33.37, a price-to-earnings-growth ratio of 0.40 and a beta of 0.61. The company has a current ratio of 2.31, a quick ratio of 2.12 and a debt-to-equity ratio of 0.63.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). Liquidia had a return on equity of 149.65% and a net margin of 30.74%. The business had revenue of $171.68 million during the quarter, compared to analyst estimates of $168.48 million. During the same period in the previous year, the business posted ($0.49) earnings per share. The firm’s quarterly revenue was up 1842.1% on a year-over-year basis. On average, research analysts predict that Liquidia Corporation will post 2.05 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on LQDA. Wedbush set a $58.00 target price on shares of Liquidia in a report on Friday, October 2nd. Jefferies Financial Group raised shares of Liquidia to a “strong-buy” rating in a research report on Thursday, October 1st. Piper Sandler set a $129.00 price target on shares of Liquidia in a research note on Friday, July 24th. Stephens set a $130.00 price target on shares of Liquidia in a report on Friday, July 24th. Finally, Wells Fargo & Company boosted their price objective on shares of Liquidia from $30.00 to $33.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 14th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $72.85.

Institutional Trading of Liquidia

A number of institutional investors have recently modified their holdings of the company. Pinnacle Wealth Planning Services Inc. grew its stake in shares of Liquidia by 26.2% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 1,557 shares of the company’s stock valued at $47,000 after buying an additional 323 shares in the last quarter. Sterling Capital Management LLC raised its holdings in shares of Liquidia by 839.1% during the 3rd quarter. Sterling Capital Management LLC now owns 2,329 shares of the company’s stock valued at $70,000 after buying an additional 2,081 shares during the period. Nisa Investment Advisors LLC lifted its position in Liquidia by 13.8% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,634 shares of the company’s stock worth $80,000 after acquiring an additional 320 shares in the last quarter. Globeflex Capital L P acquired a new position in Liquidia during the 2nd quarter worth approximately $175,000. Finally, Nykredit A S purchased a new position in Liquidia in the 2nd quarter worth approximately $177,000. Hedge funds and other institutional investors own 64.54% of the company’s stock.

About Liquidia

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with pulmonary hypertension and other serious cardiopulmonary diseases. The company is headquartered in Research Triangle Park, North Carolina, and uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition for inhaled and injectable medicines.

Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder formulation of treprostinil delivered through a proprietary inhaler.